Cover storyCDMO trends 2026 show a structural consolidation wave — bigger deals, sharper specialization, and rising onshoring pressure reshaping manufacturing.
Cormica TPM publishes a peer-reviewed analysis of FDA enforcement trends across 503A and 503B compounding facilities, mapping recurring inspection deficiencies.
FDA issued an updated approval letter for Sanofi's TENIVAC Td vaccine on August 26, 2026, requiring regulatory teams to review revised labeling and compliance documentation.
Moleculin's MIRACLE trial nears a 90-patient interim analysis for Annamycin in R/R AML, a key checkpoint on the FDA-aligned path to registration.
FDA accepts Nicox's NCX 470 NDA and sets a 30 April 2027 PDUFA date, with U.S. launch targeted H2 2027.
Latest edition
Interview20260622153015.png&w=1920&q=75&dpl=dpl_4mCM4LkTaakSXHxN4EsrYb1NmZRR)
Interview
Interview
Podcast
Sep 28
Nov 18
Feb 03From native content to event partnerships, we help brands earn the attention of a hard-to-reach, senior audience — without breaking the reading experience.
See partnership options →Explore expert-led guides crafted for pharma professionals. Log in to download and stay ahead.
Join thousands of pharma professionals getting our sharpest reporting, briefings and guides — free.
20260804110923.webp&w=1920&q=75&dpl=dpl_4mCM4LkTaakSXHxN4EsrYb1NmZRR)
